Ready-to-use cell model architectures optimized for your applications

Empower your research with a range of 3D cell model architectures tailored to your needs. Seamlessly integrate these flexible architectures into various well-plate formats and applications, including imaging, screening, and cell extraction.

Connect with a specialist

Imaging Model

A small single-matrix architecture optimized for fast imaging and minimal cell usage. This model ensures clear imaging and compatibility with standard techniques, enabling seamless integration into your workflows. Compatible with 96-well plates on RASTRUM™ and RASTRUM Allegro.

Applications

Brightfield and immunofluorescence imaging
Drug screening
Biochemical assays

Features

Thin architecture for rapid, high-content imaging
Compact design minimizes the number of cells required while maintaining reproducibility

Figure Legend: A lung cancer co-culture model made with RASTRUM Allegro. Primary normal human lung fibroblasts (NHLFs) were printed with primary Human Umbilical Vein Endothelial Cells (HUVECs) and A549 lung adenocarcinoma cells using RASTRUM’s Imaging Model architecture. Cells were cultured for 7 days and stained using a PhenoVue Cell Painting Kit (Revvity). Cell nuclei (cyan) were labeled with Hoescht, filamentous actin (yellow) with phalloidin, and membrane glycoproteins (magenta) with concanavalin A. Inset: Imaging Model architecture illustration.

Large Plug Model

A single-matrix architecture tailored for expansion and bulk downstream analyses, delivering the cellular material you need for comprehensive studies and high-throughput applications. Compatible with 96-well plates on RASTRUM and RASTRUM Allegro.

Applications

DNA, RNA, and protein analysis
Flow cytometry
Omics analyses

Features

Larger matrix architecture for increased cellular material
Optimized for workflows requiring bulk analysis and high data yield

Figure legend. Liver co-culture created with RASTRUM. Immortalized hepatocyte and stellate cells were printed in a Large Plug Model and cultured for 5 days before treatment with TGF-β1. On Day 7 cells were retrieved from the matrix and RNA isolated. Gene expression of profibriotic markers for Collagen-type 1 (COL1A1) and connective tissue growth factor (CTGF) were shown to be significantly increased following TGF-ꞵ1 treatment.